Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
Gupta
L K
LK
Randhawa
V S
VS
D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D019540:Area Under Curve; D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007194:India; D008826:Microbial Sensitivity Tests / Q000592:standards*; D012485:Salmonella typhi / Q000187:drug effects*; D014435:Typhoid Fever / Q000188:drug therapy* / Q000382:microbiology
D000890:Anti-Infective Agents; D002939:Ciprofloxacin